Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-03 Sale |
2024-12-04 4:36 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
21,495 | $36.68 | $788,437 | 9,679 (Direct) |
View |
| 2024-11-11 Sale |
2024-11-12 4:15 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
10,700 | $36.24 | $387,768 | 130,275 (Direct) |
View |
| 2024-11-08 Sale |
2024-11-12 4:14 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director |
8,722 | $36.28 | $316,434 | 28,395 (Direct) |
View |
| 2024-11-08 Sale |
2024-11-12 4:13 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
10,787 | $36.3 | $391,568 | 13,315 (Direct) |
View |
| 2024-11-08 Sale |
2024-11-12 4:11 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
125,000 | $36.29 | $4,536,250 | 1,948,622 (Indirect Direct) |
View |
| 2024-11-07 Sale |
2024-11-08 4:13 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT |
15,000 | $36.98 | $554,700 | 8,200 (Direct) |
View |
| 2024-11-07 Sale |
2024-11-08 4:11 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
14,213 | $36.62 | $520,480 | 24,102 (Direct) |
View |
| 2024-11-07 Sale |
2024-11-08 4:08 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
125,000 | $36.68 | $4,585,000 | 2,073,622 (Indirect Direct) |
View |
| 2024-09-13 Sale |
2024-09-17 4:10 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
13,886 | $31.33 | $435,048 | 38,315 (Direct) |
View |
| 2024-03-21 Sale |
2024-03-25 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
14,491 | $35.31 | $511,677 | 21,315 (Direct) |
View |
| 2024-03-20 Sale |
2024-03-22 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
400 | $35.31 | $14,124 | 35,806 (Direct) |
View |
| 2024-03-19 Sale |
2024-03-21 5:01 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
12,364 | $35.31 | $436,573 | 36,206 (Direct) |
View |
| 2024-03-13 Sale |
2024-03-15 6:39 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
62,366 | $33.74 | $2,104,289 | 17,320 (Direct) |
View |
| 2024-03-12 Sale |
2024-03-14 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
3,884 | $32.99 | $128,133 | 44,686 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-28 5:01 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
5,000 | $30.21 | $151,050 | 8,570 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-27 Tax Withholding |
2024-12-30 4:13 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer |
1,102 | $35.59 | 6,595 (Direct) |
View |
| 2024-12-27 Exercise |
2024-12-30 4:13 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer |
2,625 | $0 | 6,595 (Direct) |
View |
| 2024-12-27 Tax Withholding |
2024-12-30 4:08 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
25,233 | $35.59 | 1,976,029 (Direct) |
View |
| 2024-12-27 Exercise |
2024-12-30 4:08 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
52,640 | $0 | 1,976,029 (Direct) |
View |
| 2024-12-23 Option Award |
2024-12-26 08:42 am |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
52,640 | $0 | 52,640 (Direct) |
View |
| 2024-12-23 Option Award |
2024-12-26 08:31 am |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer |
2,625 | $0 | 2,625 (Direct) |
View |
| 2024-12-03 Exercise |
2024-12-04 4:36 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
12,745 | $25.3 | 9,679 (Direct) |
View |
| 2024-12-03 Exercise |
2024-12-04 4:36 pm |
N/A 2030-02-21 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
21,495 | $0 | 9,679 (Direct) |
View |
| 2024-12-03 Exercise |
2024-12-04 4:36 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
8,750 | $23.99 | 9,679 (Direct) |
View |
| 2024-11-11 Exercise |
2024-11-12 4:15 pm |
2016-03-03 2025-03-03 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
20,000 | $0 | 130,275 (Direct) |
View |
| 2024-11-11 Exercise |
2024-11-12 4:15 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
20,000 | $9.13 | 130,275 (Direct) |
View |
| 2024-11-08 Exercise |
2024-11-12 4:13 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
10,787 | $11.46 | 13,315 (Direct) |
View |
| 2024-11-08 Exercise |
2024-11-12 4:13 pm |
2016-03-23 2025-03-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
10,787 | $0 | 13,315 (Direct) |
View |
| 2024-11-08 Exercise |
2024-11-12 4:11 pm |
2016-03-03 2025-03-03 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
125,000 | $0 | 1,948,622 (Direct) |
View |
| 2024-11-08 Exercise |
2024-11-12 4:11 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
125,000 | $9.13 | 1,948,622 (Direct) |
View |
| 2024-11-07 Exercise |
2024-11-08 4:13 pm |
2016-03-03 2025-03-03 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT |
15,000 | $0 | 8,200 (Direct) |
View |
| 2024-11-07 Exercise |
2024-11-08 4:13 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT |
15,000 | $9.13 | 8,200 (Direct) |
View |
| 2024-11-07 Exercise |
2024-11-08 4:11 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
14,213 | $11.46 | 24,102 (Direct) |
View |
| 2024-11-07 Exercise |
2024-11-08 4:11 pm |
2016-03-23 2025-03-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
14,213 | $0 | 24,102 (Direct) |
View |
| 2024-11-07 Exercise |
2024-11-08 4:08 pm |
2016-03-03 2025-03-03 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
125,000 | $0 | 2,073,622 (Direct) |
View |
| 2024-11-07 Exercise |
2024-11-08 4:08 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
125,000 | $9.13 | 2,073,622 (Direct) |
View |
| 2024-09-13 Exercise |
2024-09-17 4:10 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
10,000 | $11.46 | 38,315 (Direct) |
View |
| 2024-09-13 Exercise |
2024-09-17 4:10 pm |
2016-03-23 2025-03-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
10,000 | $0 | 38,315 (Direct) |
View |
| 2024-09-03 Exercise |
2024-09-03 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
21,000 | $0 | 1,948,622 (Direct) |
View |
| 2024-09-03 Tax Withholding |
2024-09-03 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
10,045 | $34.9 | 1,948,622 (Direct) |
View |
| 2024-08-27 Option Award |
2024-08-27 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
21,000 | $0 | 1,958,667 (Direct) |
View |
| 2024-08-20 Tax Withholding |
2024-08-20 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
572 | $29.57 | 9,679 (Direct) |
View |
| 2024-08-20 Exercise |
2024-08-20 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
1,250 | $0 | 9,679 (Direct) |
View |
| 2024-08-01 Option Award |
2024-08-14 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
1,250 | $0 | 10,251 (Direct) |
View |
| 2024-03-21 Exercise |
2024-03-25 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
14,491 | $25.3 | 21,315 (Direct) |
View |
| 2024-03-21 Exercise |
2024-03-25 5:00 pm |
N/A 2027-02-24 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
14,491 | $0 | 21,315 (Direct) |
View |
| 2024-03-20 Exercise |
2024-03-22 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
400 | $25.3 | 35,806 (Direct) |
View |
| 2024-03-20 Exercise |
2024-03-22 5:00 pm |
N/A 2027-02-24 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
400 | $0 | 35,806 (Direct) |
View |
| 2024-03-19 Exercise |
2024-03-21 5:01 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
12,364 | $25.3 | 36,206 (Direct) |
View |
| 2024-03-19 Exercise |
2024-03-21 5:01 pm |
N/A 2027-02-24 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
12,364 | $0 | 36,206 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 6:39 pm |
N/A 2026-03-01 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
62,366 | $0 | 17,320 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 6:39 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
36,116 | $12.98 | 17,320 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 6:39 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
26,250 | $23.99 | 17,320 (Direct) |
View |
| 2024-03-12 Exercise |
2024-03-14 5:00 pm |
N/A 2026-03-01 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
3,884 | $0 | 44,686 (Direct) |
View |
| 2024-03-12 Exercise |
2024-03-14 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
3,884 | $12.98 | 44,686 (Direct) |
View |
| 2024-02-28 Exercise |
2024-02-29 5:01 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT |
990 | $0 | 7,779 (Direct) |
View |
| 2024-02-28 Tax Withholding |
2024-02-29 5:01 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT |
460 | $27.94 | 7,779 (Direct) |
View |
| 2024-02-28 Exercise |
2024-02-29 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
35,000 | $0 | 1,937,667 (Direct) |
View |
| 2024-02-28 Tax Withholding |
2024-02-29 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
16,788 | $27.94 | 1,937,667 (Direct) |
View |
| 2024-02-26 Exercise |
2024-02-28 5:01 pm |
N/A 2025-03-03 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
5,000 | $0 | 8,570 (Direct) |
View |
| 2024-02-26 Exercise |
2024-02-28 5:01 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
5,000 | $9.13 | 8,570 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 5:04 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
3,886 | $0 | 120,975 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 5:04 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director |
3,886 | $0 | 17,201 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 5:04 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
3,886 | $0 | 17,201 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 5:03 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director |
3,886 | $0 | 37,117 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 5:02 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director |
3,886 | $0 | 87,943 (Direct) |
View |
| 2024-02-23 Tax Withholding |
2024-02-27 5:02 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT |
937 | $29.06 | 12,874 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 5:02 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT |
1,875 | $0 | 12,874 (Direct) |
View |
| 2024-02-23 Tax Withholding |
2024-02-27 5:01 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
638 | $29.06 | 12,320 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 5:01 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
1,250 | $0 | 12,320 (Direct) |
View |
| 2024-02-23 Tax Withholding |
2024-02-27 5:01 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO |
1,314 | $29.06 | 14,690 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 5:01 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO |
2,500 | $0 | 14,690 (Direct) |
View |
| 2024-02-23 Tax Withholding |
2024-02-27 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer |
567 | $29.06 | 8,391 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer |
1,250 | $0 | 8,391 (Direct) |
View |
| 2024-02-23 Tax Withholding |
2024-02-27 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
485 | $29.06 | 90,683 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
1,250 | $0 | 90,683 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 5:03 pm |
N/A 2034-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
13,621 | $0 | 26,936 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 5:02 pm |
N/A 2034-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director |
13,621 | $0 | 26,936 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 5:02 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer |
30,750 | $0 | 35,458 (Direct) |
View |
| 2024-02-22 Tax Withholding |
2024-02-26 5:02 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer |
303 | $27.94 | 35,458 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 5:02 pm |
N/A 2034-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
13,621 | $0 | 130,710 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 5:02 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
25,750 | $0 | 34,458 (Direct) |
View |
| 2024-02-22 Tax Withholding |
2024-02-26 5:02 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
372 | $27.94 | 34,458 (Direct) |
View |